| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8bb60534b9af07898e674688c22e8ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f47dfb7d74b955d98abe1c9eb61dac06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ddc26424bc86bd924929fb25ef4d839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c15d8da9e0f62445431434d9fd925b18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec1ad21e15d585844a671f3c8e9b0d08 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2010-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c12400b03b1c7ff12377fee895480fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90f666d5948dfb5b57da372edcae6959
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9ce9a69fa02d9a80550eb1e05245cd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f34f5bc10ec3582d9ccb09388ba46663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba41e70cba2e185cb5d9bcc0c65f3d0 |
| publicationDate |
2012-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012277253-A1 |
| titleOfInvention |
Subcutaneous paliperidone composition |
| abstract |
The present invention relates to pharmaceutical composition for subcutaneous injection comprising a paliperidone compound wherein the composition releases the paliperidone with an immediate onset of action and continuously for at least 3 weeks, and wherein the composition has a pharmacokinetic profile in vivo with substantially no burst release of the paliperidone. The compositions are useful as medicaments for the treatment of psychotic disorders and diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11304951-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439647-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10143693-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-037185-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324751-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016244801-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016164218-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2020239611-B2 |
| priorityDate |
2009-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |